In the current study, we utilized a SERT knockout mouse model, SSRI treatment, estrogen replacement, and pregnancy-induced hormonal changes to clarify the role of estrogen in the development of SERT-related obesity and metabolic abnormalities. This evidence concerns the gene SLC6A4 and obesity due to melanocortin 4 receptor deficiency.